A Global Phase 2b, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

16500FORTITUDE-HCMOpenA Global Phase 2b, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy – FORTITUDE-HCMIMB101-010NCT07023614IndustrialAdultTreatmentOtherBering, Patrick; Jani, SandeepMedstar Union Memorial Hospital; Medstar Washington Hospital Center : Jamie GuillerganMCRN - Baltimore Outpatient; MCRN - Heart Failure16692Jamie GuillerganJamie Guillerganjamie.s.guillergan@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>